JP5792059B2 - 抗血小板療法中の血小板抑制のメンテナンス - Google Patents
抗血小板療法中の血小板抑制のメンテナンス Download PDFInfo
- Publication number
- JP5792059B2 JP5792059B2 JP2011509659A JP2011509659A JP5792059B2 JP 5792059 B2 JP5792059 B2 JP 5792059B2 JP 2011509659 A JP2011509659 A JP 2011509659A JP 2011509659 A JP2011509659 A JP 2011509659A JP 5792059 B2 JP5792059 B2 JP 5792059B2
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- platelet
- patient
- item
- reversible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Description
および何らかの理由で、クロピドグレルまたはプラビックスなどの持続的なチエノピリジ
ンを投与することができない患者で使用することができる。
例えば、本願発明は以下の項目を提供する。
(項目1)
以前に少なくとも1つのチエノピリジンで治療された患者の病気または状態を、治療ま
たは予防する方法であって、侵襲的手法の前に、前記患者に有効量の少なくとも1つの可
逆的な、短時間作用型のP2Y 12 抑制剤を投与することを含む、方法。
(項目2)
前記侵襲的手法は冠状動脈バイパス移植である、項目1に記載の方法。
(項目3)
前記侵襲的手法は経皮的冠動脈形成である、項目1に記載の方法。
(項目4)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤はカングレロールで
ある、項目1に記載の方法。
(項目5)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤の投与を、前記侵襲
的手法の5日前以内に行う、項目1に記載の方法。
(項目6)
以前に少なくとも1つのチエノピリジンで治療された患者の病気または状態を、治療ま
たは予防する方法であって、前記患者に有効量の少なくとも1つの可逆的な、短時間作用
型のP2Y 12 抑制剤を投与して、少なくとも部分的に前記患者の血小板活性を抑制する
ことを含む、方法。
(項目7)
前記患者は以前にステントを受けた、項目6に記載の方法。
(項目8)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤は、カングレロール
である、項目6に記載の方法。
(項目9)
前記ステントがベア金属ステントである、項目7に記載の方法。
(項目10)
前記ステントが薬物溶出ステントである、項目7に記載の方法。
(項目11)
患者の血小板活性を少なくとも部分的に抑制する方法であって、
有効量の少なくとも1つのチエノピリジンを投与すること、
前記少なくとも1つのチエノピリジンの投与を中止後に、有効量の少なくとも1つの可
逆的な、短時間作用型のP2Y 12 抑制剤を投与すること
を含む、方法。
(項目12)
前記少なくとも1つのチエノピリジンは不可逆的である、項目11に記載の方法。
(項目13)
少なくとも1つのチエノピリジンはクロピドグレルである、項目11に記載の方法。
(項目14)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤は、カングレロール
である、項目11に記載の方法。
(項目15)
前記カングレロールの有効量は、0.5〜2.0μg/kg/分の間の静脈内注入であ
る、項目14に記載の方法。
(項目16)
血小板抑制が約60%より大きい、項目11に記載の方法。
(項目17)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤の投与は、患者に実
施される侵襲的手法の前の5日以内に行われる、項目11に記載の方法。
(項目18)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤の投与は、患者に実
施される侵襲的手法の間に行われる、項目11に記載の方法。
(項目19)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤の投与は、患者に実
施される侵襲的手法の後に行われる、項目11に記載の方法。
(項目20)
以前に少なくとも1つのチエノピリジンで治療された患者の血小板活性を少なくとも部
分的に抑制する方法であって、前記患者に有効量の少なくとも1つの可逆的な、短時間作
用型のP2Y 12 抑制剤を投与することを含む、方法。
(項目21)
前記少なくとも1つのチエノピリジンがクロピドグレルである、項目20に記載の方
法。
(項目22)
前記可逆的な、短時間作用型のP2Y 12 抑制剤がカングレロールである、項目20
に記載の方法。
(項目23)
前記カングレロールの投与は、侵襲的手法の少なくとも5日前に始まる、項目20に
記載の方法。
(項目24)
前記カングレロールの投与は、前記侵襲的手法の1〜24時間前に中止される、項目
23に記載の方法。
(項目25)
患者の血小板活性を抑制する方法であって、
(a)治療を必要とする患者に、治療的に有効量の、少なくとも1つのチエノピリジンを
投与すること、
(b)前記患者に、前記少なくとも1つのチエノピリジンの投与を中止すること、
(c)血小板活性を抑制する、治療的に有効量の、少なくとも1つの可逆的な、短時間作
用型のP2Y 12 抑制剤を、前記患者に投与すること
を含む、方法。
(項目26)
前記少なくとも1つのチエノピリジンの抑制活性が不可逆的である、項目25に記載
の方法。
(項目27)
前記少なくとも1つのチエノピリジンがクロピドグレルである、項目25に記載の方
法。
(項目28)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤がカングレロールで
ある、項目25に記載の方法。
(項目29)
前記治療的に有効量のカングレロールが、約0.5〜2.0μg/kg/分の間の静脈
内注入である、項目25に記載の方法。
(項目30)
前記血小板活性の抑制は、血小板凝集の約60%を超える抑制である、項目25に記
載の方法。
(項目31)
前記患者への前記少なくとも1つのチエノピリジンの投与の中止が、患者に実施される
侵襲的手法の少なくとも5日前に行われる、項目25に記載の方法。
(項目32)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤の投与は、侵襲的手
法の前に始まる、項目31に記載の方法。
(項目33)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤の投与は、侵襲的手
法の間に始まる、項目31に記載の方法。
(項目34)
前記少なくとも1つの可逆的な、短時間作用型のP2Y 12 抑制剤の投与は、侵襲的手
法の後に始まる、項目31に記載の方法。
(項目35)
前記血小板活性が血小板凝集である、項目25に記載の方法。
最初の例では、VerifyNow(登録商標)P2Y12で測定される血小板抑制が約60%を超えるレベルに達するか、または2.0μg/kg/分の投与量まで達するまで、カングレロールは静脈内注入によって投与されることができ、かつ患者群に段階的に予め定められた投与量(0.5μg/kg/分、0.75μg/kg/分、1.0μg/kg/分、および1.5μg/kg/分)で投与することができる。
もう一つの実施例で、そして、本発明の1つの実施例にしたがって、 少なくとも1つの可逆的な、短時間作用型のP2Y12抑制剤の投与が、患者に実施されている侵襲的手法の間、行われる。このように、患者が経口的に治療法を受けることができない場合、抑制剤の投与は静注で行われると考えられる。
もう一つの実施例において、そして、本発明のもう一つの実施例にしたがって、侵襲的手法が患者に関して実行された後、少なくとも1つの可逆的な、短時間作用型のP2Y12抑制剤の投与を行う。術後計画における抑制剤の投与は、上記の様々な方法で行うことができる。例えば、患者が昏睡状態であるなどの、患者を経口的に治療することができない場合、抑制剤の投与は静注で行うこともあると考えられる。
術後期間の初めにカングレロールを使うための研究
移植されたステントの患者のPCI後の抗血小板維持療法のケアの現在の標準は、技法後のステント血栓症を防止するために、ステントの型にしたがって、二剤併用抗血小板治療の早期開始と、PCI後6〜12ヵ月までのアスピリンおよびクロピドグレルによる維持療法の継続を示唆している、米国大学心臓学/米国心臓協会(ACC/AHA)ガイドラインの推奨に基づく(Fleisher LA, et al,. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the ACC/AHA Task Force on Practice Guidelines. Circulation. 2007 Oct 23; 116(17): e418−99)。アスピリンとクロピドグレルは不可逆性の血小板拮抗剤であるため、ACC/AHAガイドラインでは、リスクを最小にするため、緊急でない外科的手法の前のクロピドグレルの休止を推奨している。
(1)VerifyNow(登録商標)P2Y12テストを使用する血小板凝集、(2)血行動態の測定、(3)血液検査、(4)少量の毛細管出血症状(点状出血、血腫)についての臨床所見、(5)潜在的な出血性合併症(血の蓄積)を検出する必要がある場合は、CT、MRI、USを使用する、頭蓋内、腹膜および胸膜腔の画像診断。
Claims (15)
- 以前に少なくとも1つのチエノピリジンで治療された患者において侵襲的手法の前に少なくとも部分的に血小板活性を抑制する方法に用いるための、薬学的処方物であって、該薬学的処方物は、カングレロールを含み、該方法が、該処方物を該患者に静脈内注入として投与する工程と、該患者に対して該侵襲的手法を実施する前に該投与を中止する工程とを包含し、該静脈内注入が、0.75μg/kg/分での注入である、薬学的処方物。
- 前記少なくとも1つのチエノピリジンによる抑制作用が不可逆的である、請求項1に記載の薬学的処方物。
- 前記少なくとも1つのチエノピリジンがクロピドグレルである、請求項1または2に記載の薬学的処方物。
- 前記薬学的処方物を投与する前に、前記少なくとも1つのチエノピリジンによる治療を中止する、請求項1〜3のいずれか1項に記載の薬学的処方物。
- 前記少なくとも1つのチエノピリジンの患者への投与が、患者への侵襲的手法を実施する少なくとも5日前に中止される、請求項4に記載の薬学的処方物。
- 前記薬学的処方物の投与が、前記侵襲的手法の前の5日以内に行われる、請求項1に記載の薬学的処方物。
- 前記薬学的処方物の投与が、前記侵襲的手法の少なくとも5日前に始まる、請求項1に記載の薬学的処方物。
- 前記薬学的処方物の投与が、前記侵襲的手法の1〜24時間前に中止される、請求項7に記載の薬学的処方物。
- 前記侵襲的手法が冠状動脈バイパス移植である、請求項5〜8のいずれか1項に記載の薬学的処方物。
- 前記侵襲的手法が経皮的冠動脈形成である、請求項5〜8のいずれか1項に記載の薬学的処方物。
- 前記患者は以前にステント移植を受けたことがある、請求項1〜3のいずれか1項に記載の薬学的処方物。
- 前記ステント移植がベア金属ステント移植である、請求項11に記載の薬学的処方物。
- 前記ステント移植が薬物溶出ステント移植である、請求項11に記載の薬学的処方物。
- 血小板活性の前記抑制が60%より大きい抑制である、請求項1〜13のいずれか1項に記載の薬学的処方物。
- 前記血小板活性が血小板凝集である、請求項1〜14のいずれか1項に記載の薬学的処方物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12741408P | 2008-05-13 | 2008-05-13 | |
US61/127,414 | 2008-05-13 | ||
PCT/US2009/043820 WO2009140407A1 (en) | 2008-05-13 | 2009-05-13 | Maintenance of platelet inhibition during antiplatelet therapy |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013260851A Division JP2014077005A (ja) | 2008-05-13 | 2013-12-18 | 抗血小板療法中の血小板抑制のメンテナンス |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011520899A JP2011520899A (ja) | 2011-07-21 |
JP2011520899A5 JP2011520899A5 (ja) | 2012-04-12 |
JP5792059B2 true JP5792059B2 (ja) | 2015-10-07 |
Family
ID=41319000
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011509659A Active JP5792059B2 (ja) | 2008-05-13 | 2009-05-13 | 抗血小板療法中の血小板抑制のメンテナンス |
JP2013260851A Pending JP2014077005A (ja) | 2008-05-13 | 2013-12-18 | 抗血小板療法中の血小板抑制のメンテナンス |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013260851A Pending JP2014077005A (ja) | 2008-05-13 | 2013-12-18 | 抗血小板療法中の血小板抑制のメンテナンス |
Country Status (17)
Country | Link |
---|---|
US (2) | US8871736B2 (ja) |
EP (1) | EP2276541B1 (ja) |
JP (2) | JP5792059B2 (ja) |
CN (1) | CN102089035A (ja) |
AU (1) | AU2009246396B2 (ja) |
BR (1) | BRPI0912693B8 (ja) |
CA (1) | CA2724470C (ja) |
CY (1) | CY1118653T1 (ja) |
DK (1) | DK2276541T3 (ja) |
ES (1) | ES2601524T3 (ja) |
HR (1) | HRP20161443T1 (ja) |
HU (1) | HUE031704T2 (ja) |
LT (1) | LT2276541T (ja) |
PL (1) | PL2276541T3 (ja) |
PT (1) | PT2276541T (ja) |
SI (1) | SI2276541T1 (ja) |
WO (2) | WO2009140092A1 (ja) |
Families Citing this family (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8759316B2 (en) | 2008-05-13 | 2014-06-24 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US20130303477A1 (en) | 2008-05-13 | 2013-11-14 | The Medicines Company | Maintenance of Platelet Inhibition During Antiplatelet Therapy |
US8680052B1 (en) * | 2013-03-09 | 2014-03-25 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
WO2009140092A1 (en) | 2008-05-13 | 2009-11-19 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US9427448B2 (en) | 2009-11-11 | 2016-08-30 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
US20120141468A1 (en) * | 2008-05-13 | 2012-06-07 | Lisa Ruderman Chen | Maintenance of platelet inhibition during antiplatelet therapy |
CA2778880C (en) * | 2009-11-11 | 2018-02-13 | The Medicines Company | Methods of treating or preventing stent thrombosis |
US10376532B2 (en) | 2009-11-11 | 2019-08-13 | Chiesi Farmaceutici, S.P.A. | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
EP2672975B1 (en) | 2011-02-09 | 2016-04-20 | The Medicines Company | Methods for treating pulmonary hypertension |
US11871901B2 (en) | 2012-05-20 | 2024-01-16 | Cilag Gmbh International | Method for situational awareness for surgical network or surgical network connected device capable of adjusting function based on a sensed situation or usage |
ES2904256T3 (es) * | 2013-03-09 | 2022-04-04 | Chiesi Farm Spa | Métodos para tratar, reducir la incidencia de y/o prevenir eventos isquémicos |
WO2014209389A1 (en) * | 2013-06-26 | 2014-12-31 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US11504192B2 (en) | 2014-10-30 | 2022-11-22 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
KR102440847B1 (ko) | 2015-01-14 | 2022-09-06 | 키에시 파르마슈티시 엣스. 피. 에이. | 고순도의 칸그렐러를 포함하는 약제학적 제제, 및 이들의 제조 및 사용 방법 |
BR112019022676A2 (pt) * | 2017-06-23 | 2020-05-19 | Chiesi Farm Spa | método de prevenção de trombose de derivação da artéria sistêmica-para-pulmonar |
US11291510B2 (en) | 2017-10-30 | 2022-04-05 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11801098B2 (en) | 2017-10-30 | 2023-10-31 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11911045B2 (en) | 2017-10-30 | 2024-02-27 | Cllag GmbH International | Method for operating a powered articulating multi-clip applier |
US11510741B2 (en) | 2017-10-30 | 2022-11-29 | Cilag Gmbh International | Method for producing a surgical instrument comprising a smart electrical system |
US11071560B2 (en) | 2017-10-30 | 2021-07-27 | Cilag Gmbh International | Surgical clip applier comprising adaptive control in response to a strain gauge circuit |
US11045197B2 (en) | 2017-10-30 | 2021-06-29 | Cilag Gmbh International | Clip applier comprising a movable clip magazine |
US11317919B2 (en) | 2017-10-30 | 2022-05-03 | Cilag Gmbh International | Clip applier comprising a clip crimping system |
US11564756B2 (en) | 2017-10-30 | 2023-01-31 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11311342B2 (en) | 2017-10-30 | 2022-04-26 | Cilag Gmbh International | Method for communicating with surgical instrument systems |
US11229436B2 (en) | 2017-10-30 | 2022-01-25 | Cilag Gmbh International | Surgical system comprising a surgical tool and a surgical hub |
US11202570B2 (en) | 2017-12-28 | 2021-12-21 | Cilag Gmbh International | Communication hub and storage device for storing parameters and status of a surgical device to be shared with cloud based analytics systems |
US10944728B2 (en) | 2017-12-28 | 2021-03-09 | Ethicon Llc | Interactive surgical systems with encrypted communication capabilities |
US11308075B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Surgical network, instrument, and cloud responses based on validation of received dataset and authentication of its source and integrity |
US10892899B2 (en) | 2017-12-28 | 2021-01-12 | Ethicon Llc | Self describing data packets generated at an issuing instrument |
US11602393B2 (en) | 2017-12-28 | 2023-03-14 | Cilag Gmbh International | Surgical evacuation sensing and generator control |
US10987178B2 (en) | 2017-12-28 | 2021-04-27 | Ethicon Llc | Surgical hub control arrangements |
US11786251B2 (en) | 2017-12-28 | 2023-10-17 | Cilag Gmbh International | Method for adaptive control schemes for surgical network control and interaction |
US11304763B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Image capturing of the areas outside the abdomen to improve placement and control of a surgical device in use |
US11253315B2 (en) | 2017-12-28 | 2022-02-22 | Cilag Gmbh International | Increasing radio frequency to create pad-less monopolar loop |
US11832899B2 (en) | 2017-12-28 | 2023-12-05 | Cilag Gmbh International | Surgical systems with autonomously adjustable control programs |
US11857152B2 (en) | 2017-12-28 | 2024-01-02 | Cilag Gmbh International | Surgical hub spatial awareness to determine devices in operating theater |
US10898622B2 (en) | 2017-12-28 | 2021-01-26 | Ethicon Llc | Surgical evacuation system with a communication circuit for communication between a filter and a smoke evacuation device |
US11179208B2 (en) | 2017-12-28 | 2021-11-23 | Cilag Gmbh International | Cloud-based medical analytics for security and authentication trends and reactive measures |
US11234756B2 (en) | 2017-12-28 | 2022-02-01 | Cilag Gmbh International | Powered surgical tool with predefined adjustable control algorithm for controlling end effector parameter |
US11818052B2 (en) | 2017-12-28 | 2023-11-14 | Cilag Gmbh International | Surgical network determination of prioritization of communication, interaction, or processing based on system or device needs |
US10849697B2 (en) | 2017-12-28 | 2020-12-01 | Ethicon Llc | Cloud interface for coupled surgical devices |
US11160605B2 (en) | 2017-12-28 | 2021-11-02 | Cilag Gmbh International | Surgical evacuation sensing and motor control |
US11432885B2 (en) | 2017-12-28 | 2022-09-06 | Cilag Gmbh International | Sensing arrangements for robot-assisted surgical platforms |
US11109866B2 (en) | 2017-12-28 | 2021-09-07 | Cilag Gmbh International | Method for circular stapler control algorithm adjustment based on situational awareness |
US11069012B2 (en) | 2017-12-28 | 2021-07-20 | Cilag Gmbh International | Interactive surgical systems with condition handling of devices and data capabilities |
US10758310B2 (en) | 2017-12-28 | 2020-09-01 | Ethicon Llc | Wireless pairing of a surgical device with another device within a sterile surgical field based on the usage and situational awareness of devices |
US11364075B2 (en) | 2017-12-28 | 2022-06-21 | Cilag Gmbh International | Radio frequency energy device for delivering combined electrical signals |
US11666331B2 (en) | 2017-12-28 | 2023-06-06 | Cilag Gmbh International | Systems for detecting proximity of surgical end effector to cancerous tissue |
US11317937B2 (en) | 2018-03-08 | 2022-05-03 | Cilag Gmbh International | Determining the state of an ultrasonic end effector |
US11291495B2 (en) | 2017-12-28 | 2022-04-05 | Cilag Gmbh International | Interruption of energy due to inadvertent capacitive coupling |
US11969142B2 (en) | 2017-12-28 | 2024-04-30 | Cilag Gmbh International | Method of compressing tissue within a stapling device and simultaneously displaying the location of the tissue within the jaws |
US10966791B2 (en) | 2017-12-28 | 2021-04-06 | Ethicon Llc | Cloud-based medical analytics for medical facility segmented individualization of instrument function |
US11389164B2 (en) | 2017-12-28 | 2022-07-19 | Cilag Gmbh International | Method of using reinforced flexible circuits with multiple sensors to optimize performance of radio frequency devices |
US11589888B2 (en) | 2017-12-28 | 2023-02-28 | Cilag Gmbh International | Method for controlling smart energy devices |
US11257589B2 (en) | 2017-12-28 | 2022-02-22 | Cilag Gmbh International | Real-time analysis of comprehensive cost of all instrumentation used in surgery utilizing data fluidity to track instruments through stocking and in-house processes |
US11304720B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Activation of energy devices |
US11147607B2 (en) | 2017-12-28 | 2021-10-19 | Cilag Gmbh International | Bipolar combination device that automatically adjusts pressure based on energy modality |
US11540855B2 (en) | 2017-12-28 | 2023-01-03 | Cilag Gmbh International | Controlling activation of an ultrasonic surgical instrument according to the presence of tissue |
US11311306B2 (en) | 2017-12-28 | 2022-04-26 | Cilag Gmbh International | Surgical systems for detecting end effector tissue distribution irregularities |
US11213359B2 (en) | 2017-12-28 | 2022-01-04 | Cilag Gmbh International | Controllers for robot-assisted surgical platforms |
US10932872B2 (en) | 2017-12-28 | 2021-03-02 | Ethicon Llc | Cloud-based medical analytics for linking of local usage trends with the resource acquisition behaviors of larger data set |
US20190201146A1 (en) | 2017-12-28 | 2019-07-04 | Ethicon Llc | Safety systems for smart powered surgical stapling |
US11304745B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Surgical evacuation sensing and display |
US11571234B2 (en) | 2017-12-28 | 2023-02-07 | Cilag Gmbh International | Temperature control of ultrasonic end effector and control system therefor |
US11410259B2 (en) | 2017-12-28 | 2022-08-09 | Cilag Gmbh International | Adaptive control program updates for surgical devices |
US11659023B2 (en) | 2017-12-28 | 2023-05-23 | Cilag Gmbh International | Method of hub communication |
US11266468B2 (en) | 2017-12-28 | 2022-03-08 | Cilag Gmbh International | Cooperative utilization of data derived from secondary sources by intelligent surgical hubs |
US20190201087A1 (en) | 2017-12-28 | 2019-07-04 | Ethicon Llc | Smoke evacuation system including a segmented control circuit for interactive surgical platform |
US11633237B2 (en) | 2017-12-28 | 2023-04-25 | Cilag Gmbh International | Usage and technique analysis of surgeon / staff performance against a baseline to optimize device utilization and performance for both current and future procedures |
US11076921B2 (en) | 2017-12-28 | 2021-08-03 | Cilag Gmbh International | Adaptive control program updates for surgical hubs |
US11937769B2 (en) | 2017-12-28 | 2024-03-26 | Cilag Gmbh International | Method of hub communication, processing, storage and display |
US11464535B2 (en) | 2017-12-28 | 2022-10-11 | Cilag Gmbh International | Detection of end effector emersion in liquid |
US11844579B2 (en) | 2017-12-28 | 2023-12-19 | Cilag Gmbh International | Adjustments based on airborne particle properties |
US11464559B2 (en) | 2017-12-28 | 2022-10-11 | Cilag Gmbh International | Estimating state of ultrasonic end effector and control system therefor |
US11056244B2 (en) | 2017-12-28 | 2021-07-06 | Cilag Gmbh International | Automated data scaling, alignment, and organizing based on predefined parameters within surgical networks |
US11864728B2 (en) | 2017-12-28 | 2024-01-09 | Cilag Gmbh International | Characterization of tissue irregularities through the use of mono-chromatic light refractivity |
US11896443B2 (en) | 2017-12-28 | 2024-02-13 | Cilag Gmbh International | Control of a surgical system through a surgical barrier |
US11132462B2 (en) | 2017-12-28 | 2021-09-28 | Cilag Gmbh International | Data stripping method to interrogate patient records and create anonymized record |
US11026751B2 (en) | 2017-12-28 | 2021-06-08 | Cilag Gmbh International | Display of alignment of staple cartridge to prior linear staple line |
US11903601B2 (en) | 2017-12-28 | 2024-02-20 | Cilag Gmbh International | Surgical instrument comprising a plurality of drive systems |
US11998193B2 (en) | 2017-12-28 | 2024-06-04 | Cilag Gmbh International | Method for usage of the shroud as an aspect of sensing or controlling a powered surgical device, and a control algorithm to adjust its default operation |
US20190201042A1 (en) | 2017-12-28 | 2019-07-04 | Ethicon Llc | Determining the state of an ultrasonic electromechanical system according to frequency shift |
US11166772B2 (en) | 2017-12-28 | 2021-11-09 | Cilag Gmbh International | Surgical hub coordination of control and communication of operating room devices |
US11896322B2 (en) | 2017-12-28 | 2024-02-13 | Cilag Gmbh International | Sensing the patient position and contact utilizing the mono-polar return pad electrode to provide situational awareness to the hub |
US11832840B2 (en) | 2017-12-28 | 2023-12-05 | Cilag Gmbh International | Surgical instrument having a flexible circuit |
US11771487B2 (en) | 2017-12-28 | 2023-10-03 | Cilag Gmbh International | Mechanisms for controlling different electromechanical systems of an electrosurgical instrument |
US11424027B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Method for operating surgical instrument systems |
US11376002B2 (en) | 2017-12-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument cartridge sensor assemblies |
US11419630B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Surgical system distributed processing |
US10943454B2 (en) | 2017-12-28 | 2021-03-09 | Ethicon Llc | Detection and escalation of security responses of surgical instruments to increasing severity threats |
US11423007B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Adjustment of device control programs based on stratified contextual data in addition to the data |
US11786245B2 (en) | 2017-12-28 | 2023-10-17 | Cilag Gmbh International | Surgical systems with prioritized data transmission capabilities |
US11529187B2 (en) | 2017-12-28 | 2022-12-20 | Cilag Gmbh International | Surgical evacuation sensor arrangements |
US11446052B2 (en) | 2017-12-28 | 2022-09-20 | Cilag Gmbh International | Variation of radio frequency and ultrasonic power level in cooperation with varying clamp arm pressure to achieve predefined heat flux or power applied to tissue |
US11559308B2 (en) | 2017-12-28 | 2023-01-24 | Cilag Gmbh International | Method for smart energy device infrastructure |
US11419667B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Ultrasonic energy device which varies pressure applied by clamp arm to provide threshold control pressure at a cut progression location |
US11969216B2 (en) | 2017-12-28 | 2024-04-30 | Cilag Gmbh International | Surgical network recommendations from real time analysis of procedure variables against a baseline highlighting differences from the optimal solution |
US11559307B2 (en) | 2017-12-28 | 2023-01-24 | Cilag Gmbh International | Method of robotic hub communication, detection, and control |
US11284936B2 (en) | 2017-12-28 | 2022-03-29 | Cilag Gmbh International | Surgical instrument having a flexible electrode |
US11744604B2 (en) | 2017-12-28 | 2023-09-05 | Cilag Gmbh International | Surgical instrument with a hardware-only control circuit |
US11678881B2 (en) | 2017-12-28 | 2023-06-20 | Cilag Gmbh International | Spatial awareness of surgical hubs in operating rooms |
US11324557B2 (en) | 2017-12-28 | 2022-05-10 | Cilag Gmbh International | Surgical instrument with a sensing array |
US11278281B2 (en) | 2017-12-28 | 2022-03-22 | Cilag Gmbh International | Interactive surgical system |
US11304699B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Method for adaptive control schemes for surgical network control and interaction |
US10892995B2 (en) | 2017-12-28 | 2021-01-12 | Ethicon Llc | Surgical network determination of prioritization of communication, interaction, or processing based on system or device needs |
US11100631B2 (en) | 2017-12-28 | 2021-08-24 | Cilag Gmbh International | Use of laser light and red-green-blue coloration to determine properties of back scattered light |
US11576677B2 (en) | 2017-12-28 | 2023-02-14 | Cilag Gmbh International | Method of hub communication, processing, display, and cloud analytics |
US11096693B2 (en) | 2017-12-28 | 2021-08-24 | Cilag Gmbh International | Adjustment of staple height of at least one row of staples based on the sensed tissue thickness or force in closing |
US11051876B2 (en) | 2017-12-28 | 2021-07-06 | Cilag Gmbh International | Surgical evacuation flow paths |
US10695081B2 (en) | 2017-12-28 | 2020-06-30 | Ethicon Llc | Controlling a surgical instrument according to sensed closure parameters |
US11273001B2 (en) | 2017-12-28 | 2022-03-15 | Cilag Gmbh International | Surgical hub and modular device response adjustment based on situational awareness |
US11013563B2 (en) | 2017-12-28 | 2021-05-25 | Ethicon Llc | Drive arrangements for robot-assisted surgical platforms |
US11259830B2 (en) | 2018-03-08 | 2022-03-01 | Cilag Gmbh International | Methods for controlling temperature in ultrasonic device |
US11534196B2 (en) | 2018-03-08 | 2022-12-27 | Cilag Gmbh International | Using spectroscopy to determine device use state in combo instrument |
US11986233B2 (en) | 2018-03-08 | 2024-05-21 | Cilag Gmbh International | Adjustment of complex impedance to compensate for lost power in an articulating ultrasonic device |
US11213294B2 (en) | 2018-03-28 | 2022-01-04 | Cilag Gmbh International | Surgical instrument comprising co-operating lockout features |
US11219453B2 (en) | 2018-03-28 | 2022-01-11 | Cilag Gmbh International | Surgical stapling devices with cartridge compatible closure and firing lockout arrangements |
US11278280B2 (en) | 2018-03-28 | 2022-03-22 | Cilag Gmbh International | Surgical instrument comprising a jaw closure lockout |
US10973520B2 (en) | 2018-03-28 | 2021-04-13 | Ethicon Llc | Surgical staple cartridge with firing member driven camming assembly that has an onboard tissue cutting feature |
US11090047B2 (en) | 2018-03-28 | 2021-08-17 | Cilag Gmbh International | Surgical instrument comprising an adaptive control system |
US11096688B2 (en) | 2018-03-28 | 2021-08-24 | Cilag Gmbh International | Rotary driven firing members with different anvil and channel engagement features |
US11207067B2 (en) | 2018-03-28 | 2021-12-28 | Cilag Gmbh International | Surgical stapling device with separate rotary driven closure and firing systems and firing member that engages both jaws while firing |
US11589865B2 (en) | 2018-03-28 | 2023-02-28 | Cilag Gmbh International | Methods for controlling a powered surgical stapler that has separate rotary closure and firing systems |
US11471156B2 (en) | 2018-03-28 | 2022-10-18 | Cilag Gmbh International | Surgical stapling devices with improved rotary driven closure systems |
US11369377B2 (en) | 2019-02-19 | 2022-06-28 | Cilag Gmbh International | Surgical stapling assembly with cartridge based retainer configured to unlock a firing lockout |
US11357503B2 (en) | 2019-02-19 | 2022-06-14 | Cilag Gmbh International | Staple cartridge retainers with frangible retention features and methods of using same |
US11331101B2 (en) | 2019-02-19 | 2022-05-17 | Cilag Gmbh International | Deactivator element for defeating surgical stapling device lockouts |
US11317915B2 (en) | 2019-02-19 | 2022-05-03 | Cilag Gmbh International | Universal cartridge based key feature that unlocks multiple lockout arrangements in different surgical staplers |
US11464511B2 (en) | 2019-02-19 | 2022-10-11 | Cilag Gmbh International | Surgical staple cartridges with movable authentication key arrangements |
USD952144S1 (en) | 2019-06-25 | 2022-05-17 | Cilag Gmbh International | Surgical staple cartridge retainer with firing system authentication key |
USD950728S1 (en) | 2019-06-25 | 2022-05-03 | Cilag Gmbh International | Surgical staple cartridge |
USD964564S1 (en) | 2019-06-25 | 2022-09-20 | Cilag Gmbh International | Surgical staple cartridge retainer with a closure system authentication key |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2530247B1 (fr) * | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
US5256559A (en) | 1988-03-04 | 1993-10-26 | Biogen, Inc. | Methods and compositions for inhibiting platelet aggregation |
FI101150B (fi) * | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
CA2155673C (en) | 1993-02-10 | 2004-08-17 | Anthony Howard Ingall | N-alkyl-2-substituted atp analogues |
SE9604795D0 (sv) | 1996-12-20 | 1996-12-20 | Astra Pharma Prod | New pharmaceutical formulation |
SE9702680D0 (sv) | 1997-07-11 | 1997-07-11 | Astra Pharma Prod | New formulation |
SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Astra Pharma Prod | Pharmaceutical combinations |
DE60134508D1 (de) * | 2000-07-06 | 2008-07-31 | Daiichi Sankyo Co Ltd | Säure-Additionssalze von Hydropyridinderivaten |
US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US6861424B2 (en) | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
WO2005007868A2 (en) | 2003-07-08 | 2005-01-27 | Accumetrics, Inc. | Controlled platelet activation to monitor therapy of adp antagonists |
US7335648B2 (en) | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
US7749981B2 (en) * | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
WO2005087266A1 (en) | 2004-03-05 | 2005-09-22 | Vddi Pharmaceuticals | Combination therapy for inhibition of platelet aggregation |
JP2009504737A (ja) * | 2005-08-19 | 2009-02-05 | イーライ リリー アンド カンパニー | 脈管疾患の治療又は予防のためのpar−1/par−4阻害剤の使用 |
DE102006020386A1 (de) * | 2006-04-28 | 2007-10-31 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung der Thrombozytenfunktion unter Flussbedingungen |
CA2623449C (en) | 2008-03-27 | 2010-11-02 | Lance Baldo | A novel use of bivalirudin in the treatment of acute coronary syndrome |
WO2009140092A1 (en) | 2008-05-13 | 2009-11-19 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US20120141468A1 (en) | 2008-05-13 | 2012-06-07 | Lisa Ruderman Chen | Maintenance of platelet inhibition during antiplatelet therapy |
US8680052B1 (en) * | 2013-03-09 | 2014-03-25 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
US20130303477A1 (en) | 2008-05-13 | 2013-11-14 | The Medicines Company | Maintenance of Platelet Inhibition During Antiplatelet Therapy |
US9427448B2 (en) | 2009-11-11 | 2016-08-30 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
US8759316B2 (en) | 2008-05-13 | 2014-06-24 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US10376532B2 (en) | 2009-11-11 | 2019-08-13 | Chiesi Farmaceutici, S.P.A. | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
CA2778880C (en) | 2009-11-11 | 2018-02-13 | The Medicines Company | Methods of treating or preventing stent thrombosis |
WO2011134478A2 (en) | 2010-04-29 | 2011-11-03 | Thrombologic Aps | Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
-
2009
- 2009-05-04 WO PCT/US2009/042681 patent/WO2009140092A1/en active Application Filing
- 2009-05-13 AU AU2009246396A patent/AU2009246396B2/en active Active
- 2009-05-13 BR BRPI0912693A patent/BRPI0912693B8/pt active IP Right Grant
- 2009-05-13 US US12/990,332 patent/US8871736B2/en active Active
- 2009-05-13 WO PCT/US2009/043820 patent/WO2009140407A1/en active Application Filing
- 2009-05-13 LT LTEP09747490.2T patent/LT2276541T/lt unknown
- 2009-05-13 CN CN2009801266781A patent/CN102089035A/zh active Pending
- 2009-05-13 JP JP2011509659A patent/JP5792059B2/ja active Active
- 2009-05-13 PT PT97474902T patent/PT2276541T/pt unknown
- 2009-05-13 CA CA2724470A patent/CA2724470C/en active Active
- 2009-05-13 ES ES09747490.2T patent/ES2601524T3/es active Active
- 2009-05-13 EP EP09747490.2A patent/EP2276541B1/en active Active
- 2009-05-13 HU HUE09747490A patent/HUE031704T2/hu unknown
- 2009-05-13 SI SI200931550A patent/SI2276541T1/sl unknown
- 2009-05-13 PL PL09747490T patent/PL2276541T3/pl unknown
- 2009-05-13 DK DK09747490.2T patent/DK2276541T3/en active
-
2013
- 2013-12-18 JP JP2013260851A patent/JP2014077005A/ja active Pending
-
2016
- 2016-04-24 US US15/136,979 patent/US10022391B2/en active Active
- 2016-11-02 HR HRP20161443TT patent/HRP20161443T1/hr unknown
- 2016-11-03 CY CY20161101124T patent/CY1118653T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0912693A2 (pt) | 2019-01-15 |
PL2276541T3 (pl) | 2017-08-31 |
EP2276541A4 (en) | 2012-05-09 |
CA2724470C (en) | 2018-01-02 |
EP2276541B1 (en) | 2016-08-03 |
EP2276541A1 (en) | 2011-01-26 |
AU2009246396A1 (en) | 2009-11-19 |
CN102089035A (zh) | 2011-06-08 |
JP2014077005A (ja) | 2014-05-01 |
WO2009140092A1 (en) | 2009-11-19 |
WO2009140407A1 (en) | 2009-11-19 |
CA2724470A1 (en) | 2009-11-19 |
US20170049798A1 (en) | 2017-02-23 |
HUE031704T2 (hu) | 2017-07-28 |
BRPI0912693B1 (pt) | 2021-05-11 |
US20110288043A1 (en) | 2011-11-24 |
DK2276541T3 (en) | 2016-11-28 |
SI2276541T1 (sl) | 2017-02-28 |
ES2601524T3 (es) | 2017-02-15 |
PT2276541T (pt) | 2016-11-10 |
US8871736B2 (en) | 2014-10-28 |
HRP20161443T1 (hr) | 2016-12-30 |
AU2009246396B2 (en) | 2015-07-09 |
CY1118653T1 (el) | 2017-07-12 |
BRPI0912693B8 (pt) | 2021-05-25 |
LT2276541T (lt) | 2016-12-12 |
JP2011520899A (ja) | 2011-07-21 |
US10022391B2 (en) | 2018-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5792059B2 (ja) | 抗血小板療法中の血小板抑制のメンテナンス | |
US11510934B2 (en) | Maintenance of platelet inhibition during antiplatelet therapy | |
Mar et al. | Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: review of the literature and recommendations for specific populations and procedures | |
US9320754B2 (en) | Maintenance of platelet inhibition during antiplatelet therapy | |
US8759316B2 (en) | Maintenance of platelet inhibition during antiplatelet therapy | |
BR112012011298B1 (pt) | Uso de cangrelor e/ou bivalirudina na preparação de medicamentos e combinação de medicamentos | |
WO2014163656A1 (en) | Maintenance of platelet inhibition during antiplatelet therapy | |
Bendel et al. | Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation | |
WO2014209389A1 (en) | Maintenance of platelet inhibition during antiplatelet therapy | |
TW202327607A (zh) | 用於預防及治療血管栓塞病症之米爾維仙(milvexian) | |
JP6840197B2 (ja) | 虚血性事象を処置し、その発生率を低減させ、かつ/または予防する方法 | |
Benzon et al. | Neuraxial anesthesia and peripheral nerve blocks in patietns on anticoagulants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120221 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130618 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20130625 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130917 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130917 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20130917 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131017 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131029 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131030 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131107 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131218 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20131218 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140829 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150105 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150317 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150617 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150708 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150805 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5792059 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |